S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Halozyme Therapeutics Incorporated (HALO)
Halozyme Therapeutics Incorporated (HALO) Financials

HALO Halozyme Therapeutics Incorporated

39.30

0.00 (0.00%)

Pre Market

Last Updated: 07:31:51

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	102M	117.28M	152.37M	208.98M	181.5M	162.14M	221.04M	216.03M
Operating Income	56.53M	75.67M	34.06M	63.19M	74.51M	53.8M	94.46M	88.28M
Pre Tax Income	54.81M	74.41M	30.01M	73.71M	70.79M	52.24M	93.16M	101.76M
Net Income	66.77M	60.11M	22.69M	61.63M	57.7M	39.62M	74.75M	81.84M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	56.53M	76.17M	33.61M	60.93M	74.51M	53.8M	94.46M	88.28M
EBITDA	57.31M	76.45M	46.61M	92.4M	81.62M	74.26M	115.09M	111.36M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	146.69M	316.61M	151.86M	195.99M	267.59M	443.31M	660.12M	829.25M
Operating Income	-83.21M	81M	-69.33M	-67.61M	144.26M	275.9M	267.53M	337.57M
Pre Tax Income	-101.86M	61.61M	-79.79M	-72.25M	129.3M	248.52M	248.92M	348.33M
Net Income	-103.02M	62.97M	-80.33M	-72.24M	129.09M	402.71M	202.13M	281.59M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-0.748	0.417	-0.525	-0.499	0.901	2.764	1.41	2.007
EBIT	-83.21M	81M	-61.75M	-60.62M	149.68M	254.94M	264.82M	337.57M
EBITDA	-80.8M	83.16M	-66.94M	-63.54M	147.54M	278.9M	317.17M	422.43M

Halozyme Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions